HOME >> BIOLOGY >> NEWS
Higher Levels Of Protein May Predict Heart Disease

WINSTON-SALEM, N.C. -- A syndrome that scientists call the "metabolic syndrome" and that the media often term "Syndrome X" may be associated with a low-level inflammatory reaction that predicts cardiovascular disease, a Wake Forest University scientist reported at an American Heart Association meeting in Orlando.

Results from a major national study demonstrate that low-level inflammation in adults is powerfully connected to measures of insulin metabolism, according to George Howard, professor of public health sciences (biostatistics and epidemiology) at the Wake Forest University School of Medicine.

The loss of sensitivity to insulin is believed to be a major cause of diabetes, and diabetes in turn is a major cause of heart disease. "Loss of insulin sensitivity is in part due to increased low-level inflammation," he said.

The metabolic syndrome includes high blood pressure, impaired glucose tolerance, obesity, lack of sensitivity to insulin, high levels of the bad cholesterol-- LDL and low levels of the good cholesterol, HDL

One marker of inflammation is a blood protein called C-reactive protein, and as it increases, risk of heart attacks increase, he said. When the C-reactive protein is in the high normal range, it indicates low level inflammatory status.

In a study called the Insulin Resistance Atherosclerosis study (IRAS), which involves diabetics and prediabetics, Howard analyzed the average level of C-reactive protein in the blood of 1,560 participants.

The level of C-reactive protein rose as blood sugar rose: from an average of 1.5 micrograms per milliliter for people with normal blood sugar, to an average of 2.6 micrograms per milliliter for people with impaired glucose tolerance and 3.2 for diabetics. Those with blood pressure within the normal range averaged 1.8 micrograms per milliliter compared to 3.0 for people with high blood pressure.

Howard said o
'"/>

Contact: Robert Conn or Jim Steele
rconn@wfubmc.edu
336-716-4587
Wake Forest University Baptist Medical Center
29-Mar-1999


Page: 1 2

Related biology news :

1. Higher blood levels of sitosterol may be associated with increased risk for coronary events
2. Higher fibre intake linked to later periods, scientists say
3. Study: Higher energy intake, obesity affects all age groups, not just youths
4. Basic Research and Higher Education Program Conference breaks new ground
5. Higher fat diets show same positive effects on LDLs as low fat diet
6. Higher obesity rates prevail among Dutch women exposed to famine in utero
7. New Hampshire Study Shows Well Water Has Higher Arsenic Levels Than Municipal Water
8. Software Helps Decipher Genomes Of Higher Organisms
9. New Research: Children Inhale Higher Percentage Of Pollution
10. New Analytical Methods Indicate Higher Folic Acid Concentration In Beans And Peas
11. Eating Less Fat At One Meal May Lead To Higher Fat Intake Later

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Higher Levels Protein May Predict Heart Disease

(Date:10/16/2014)... challenged conventional thinking on how the bowel lining develops ... how bowel cancer starts. , The researchers produced evidence ... the ,crypts, that are a feature of the bowel ... bowel cancer development, a controversial finding as scientists are ... 3D imaging technologies, Dr Chin Wee Tan and Professor ...
(Date:10/16/2014)... Syncytial Virus causes severe respiratory tract infections and ... year. Scientists at VIB and Ghent University have ... counteract this common virus infection. , Xavier ... that paves the way for the development of ... virus that causes suffering in numerous small children ...
(Date:10/16/2014)... , October 16, 2014 NXT-ID, Inc. ... the "Company"), a biometric authentication company focused on the ... leading edge technologies including Wocket™, the Smart Wallet, at ... Conferenece. FiRe is a leading global conference on the ... Hosted by Mark Anderson , founder and publisher ...
Breaking Biology News(10 mins):Cryptic clues drive new theory of bowel cancer development 2New perspectives for development of an RSV vaccine 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3
(Date:10/25/2014)... Charlotte, NC (PRWEB) October 24, 2014 ... high intensity focused ultrasound (HIFU) technology, announced that ... Carol, M.D. as Chief Executive Officer, President and ... new role Dr. Carol will take-on expanded responsibilities ... HIFU technology, as well as overseeing commercialization, manufacturing ...
(Date:10/25/2014)... JERUSALEM , October 24, 2014 ... a clinical-stage pharmaceutical company focused on the development of ... CEO, Nadav Kidron will present at FireRock ... ,FireRock Capital,s Annual Micro-Cap Conference ,Date: Tuesday, October 28, ... Building, New York City , ...
(Date:10/25/2014)... 2014 Investor-Edge has initiated coverage ... CYTR ), Vertex Pharmaceuticals Inc. (NASDAQ: VRTX ... Peregrine Pharmaceuticals Inc. (NASDAQ: PPHM ), and ... companies can be accessed at: http://investor-edge.com/register . ... ended on a positive note as the Dow Jones ...
(Date:10/22/2014)... 22, 2014 New test innovations will be ... diagnostic (IVD) test industry, especially as companies struggle with ... listed more than 25 testing innovations in important disease ... of IVD products. Kalorama details the new approaches its biennial ... for In Vitro Diagnostic Tests , 9th Edition ...
Breaking Biology Technology:SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 2SonaCare Medical Board of Directors Appoints Dr. Mark Carol as CEO and President 3Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 2Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 3Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 4Biotech Stocks Technical Data - CytRx, Vertex Pharma, Alexion Pharma, Peregrine Pharma, and StemCells 5Report: Radical New IVD Test Approaches Key To Growth 2Report: Radical New IVD Test Approaches Key To Growth 3
Cached News: